{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:44:30Z","timestamp":1794851070791,"version":"4.9.1"},"reference-count":111,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/14760584.2025.2508517","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:43:31Z","timestamp":1747644211000},"page":"444-456","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":64,"title":["Virus-like particles: a versatile and effective vaccine platform"],"prefix":"10.1080","volume":"24","author":[{"given":"Martin F.","family":"Bachmann","sequence":"first","affiliation":[{"name":"University Hospital of Bern, Bern, Switzerland"},{"name":"University of Oxford","place":["Oxford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"van Damme","sequence":"additional","affiliation":[{"name":"University of Antwerp","place":["Antwerp, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lienert","sequence":"additional","affiliation":[{"name":"Medical Affairs, Bavarian Nordic Berna GmbH, Th\u00f6rishaus","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino F.","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine and Vaccination Centre, Klinikum W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"e_1_3_6_3_1","unstructured":"World Health Organization. Vaccines and Immunization Factsheet. 2024 [cited 2024 Sep]. Available from: https:\/\/www.who.int\/health-topics\/vaccines-and-immunization#tab=tab_1"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00479-7"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122331"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.2.306"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2017.08.014"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15051109"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00503-y"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2022.102785"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2023.01.012"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2498"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbt.2017.07.010"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2868"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002367"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1123805"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2006.07.018"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00897-8"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.02.031"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12863"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8248784"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-31668-6_10"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639040802192806"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.016"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1510533112"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1403"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0006-8"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-015-0241-5"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.115"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020479"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/applmicrobiol3030056"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1809921115"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.790121"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-024-00677-y"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2105"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201300"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37634"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13020191"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12040439"},{"issue":"1","key":"e_1_3_6_40_1","first-page":"S3","article-title":"Evolving considerations for choice of hepatitis B vaccine","volume":"29","author":"Surofchy DD","year":"2023","unstructured":"Surofchy DD, Shieh N, Tam I. Evolving considerations for choice of hepatitis B vaccine. Am J Manag Care. 2023;29(1 Suppl):S3\u2013s14.","journal-title":"Am J Manag Care"},{"key":"e_1_3_6_41_1","unstructured":"Cervarix EMA prescribing information. [cited 2024 Sep]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/overview\/cervarix-epar-summary-public_en.pdf"},{"key":"e_1_3_6_42_1","unstructured":"Cervarix FDA prescribing information. [cited 2024 Sep]. Available from: https:\/\/www.fda.gov\/media\/78013\/download"},{"key":"e_1_3_6_43_1","unstructured":"Recombivax HB prescribing information. [cited 2024 Sep]. Available from: https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/package-insert-recombivax-hb.pdf"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040323"},{"key":"e_1_3_6_45_1","unstructured":"Engerix B prescribing information. [cited 2024 Sep]. Available from: https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Engerix-B\/pdf\/ENGERIX-B.PDF"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.087"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.068"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30780-5"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.006"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61030-6"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02455-8"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60946-5"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1625644"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix797"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405044"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060993"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515257"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02511-4"},{"key":"e_1_3_6_62_1","unstructured":"Clinicaltrials.gov. Safety and immunogenicity of CHIKV VLP vaccine PXVX0317 in adults \u226565 years Available from: https:\/\/clinicaltrials.gov\/study\/NCT05349617"},{"key":"e_1_3_6_63_1","unstructured":"Clinicaltrials.gov. A phase 3 trial of the VLP-based chikungunya vaccine PXVX0317 Available from: https:\/\/clinicaltrials.gov\/study\/NCT05072080"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.2471"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00345-9"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00372-1"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.25015"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.19989"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1338568"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264062"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp288"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.11.002"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030391"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.2165\/11591760-000000000-00000"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15714"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-7-38"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa011"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00453-8"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100056"},{"key":"e_1_3_6_80_1","unstructured":"UK Government Joint Committee on Vaccination and Immunisation. JCVI statement on a one-dose schedule for the routine HPV immunisation programme. 2022 [cited 2024 Nov]. Available from: https:\/\/www.gov.uk\/government\/publications\/single-dose-of-hpv-vaccine-jcvi-concluding-advice\/jcvi-statement-on-a-one-dose-schedule-for-the-routine-hpv-immunisation-programme#appendix-evidence"},{"key":"e_1_3_6_81_1","unstructured":"Australian Government Department of Health and Aged Care. Australian immunization handbook. Human papillomavirus (HPV). [cited 2024 Nov]. Available from: https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccine-preventable-diseases\/human-papillomavirus-hpv"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077341"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30068-4"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90540-X"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1669415"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1086\/600120"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001685"},{"key":"e_1_3_6_88_1","unstructured":"WHO Malaria Policy Advisory Group (MPAG). Meeting report. [cited 2024 Sep]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/376070\/9789240089648-eng.pdf?sequence=1"},{"key":"e_1_3_6_89_1","unstructured":"Government of Canada. Post-authorization activity table for Covifenz. 2023 [cited 2025 Feb]. Available from: https:\/\/covid-vaccine.canada.ca\/info\/paat-SBD00582-covifenz-en.html"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-021-03211-0"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00809-2"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2023.100127"},{"key":"e_1_3_6_93_1","unstructured":"U.S. FDA approval of chikungunya vaccine for persons aged 12 and older. 2025 Available from: https:\/\/www.bavarian-nordic.com\/media\/media\/news.aspx?news=7053"},{"key":"e_1_3_6_94_1","unstructured":"Bavarian Nordic. Receives positive CHMP opinion for chikungunya vaccine for persons aged 12 and older. 2025 [cited 2025 Feb]. Available from: https:\/\/www.bavarian-nordic.com\/media\/media\/news.aspx?news=7046"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2388943"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.03.1394"},{"key":"e_1_3_6_97_1","unstructured":"WHO. Preferred product characteristics for respiratory syncytial virus vaccines. 2024 [cited 2024 Nov]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/258705\/WHO-IVB-17.11-eng.pdf?sequence=1"},{"key":"e_1_3_6_98_1","unstructured":"Clinicaltrials.gov. A study to evaluate the safety and immunogenicity of IVX-A12 in participants of 60 to 85 years of age. [cited 2024 Nov]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05903183"},{"key":"e_1_3_6_99_1","unstructured":"IVX-A12 phase 2 interim results. [cited 2024 Sep]. Available from: https:\/\/www.biospace.com\/icosavax-announces-positive-topline-interim-phase-2-results-for-combination-vlp-vaccine-candidate-ivx-a12-against-rsv-and-hmpv-in-older-adults"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1021500"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188431"},{"key":"e_1_3_6_102_1","unstructured":"Lopman B. Global burden of norovirus and prospects for vaccine development. CDC foundation. [cited 2025 Apr]. Available from: https:\/\/www.cdc.gov\/norovirus\/downloads\/global-burden-report.pdf"},{"key":"e_1_3_6_103_1","unstructured":"Clinicaltrials.gov. A clinical trial to evaluate the safety and immunogenicity of norovirus bivalent vaccine. [cited 2025 Apr]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04188691"},{"key":"e_1_3_6_104_1","unstructured":"Clinicaltrials.gov. Clinical trial of quadrivalent recombinant norovirus vaccine (pichia pastoris). Available from: https:\/\/clinicaltrials.gov\/study\/NCT04563533"},{"key":"e_1_3_6_105_1","unstructured":"A study to evaluate the safety and immunogenicity of recombinant trivalent poliomyelitis vaccine (Sf-RVN cell) in healthy adults. 2024 [cited 2024 Nov]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06101173"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101104"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1504124"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-061008-103129"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-024-03750-5"},{"key":"e_1_3_6_110_1","unstructured":"mRNA technology for improving global health: a report of the WHO science council. [cited 2025 Apr]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/research-for-health\/23-04-01-mrna-draft-report_for-public-consultation.pdf?sfvrsn=c10572d2_6"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106317"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15080"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0030-8"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2025.2508517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:42:30Z","timestamp":1765521750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2025.2508517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/14760584.2025.2508517"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2025.2508517","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}